Publication Information

{'id': 'https://openalex.org/W2026250203', 'doi': 'https://doi.org/10.1097/01.aids.0000218548.77457.76', 'title': 'Effect of baseline protease genotype and phenotype on HIV response to atazanavir/ritonavir in treatment-experienced patients', 'display_name': 'Effect of baseline protease genotype and phenotype on HIV response to atazanavir/ritonavir in treatment-experienced patients', 'publication_year': 2006, 'publication_date': '2006-03-20', 'ids': {'openalex': 'https://openalex.org/W2026250203', 'doi': 'https://doi.org/10.1097/01.aids.0000218548.77457.76', 'mag': '2026250203', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/16549968'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/01.aids.0000218548.77457.76', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S20605092', 'display_name': 'AIDS', 'issn_l': '0269-9370', 'issn': ['0269-9370', '1473-5571'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://doi.org/10.1097/01.aids.0000218548.77457.76', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5027568709', 'display_name': 'Lisa K. Naeger', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210149736', 'display_name': 'Food and Drug Administration', 'ror': 'https://ror.org/05hvrsg85', 'country_code': 'TH', 'type': 'government', 'lineage': ['https://openalex.org/I4210149736']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}, {'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}], 'countries': ['TH', 'US'], 'is_corresponding': True, 'raw_author_name': 'Lisa K Naeger', 'raw_affiliation_strings': ["These views represent the authors' opinion and not necessarily the views of the Food and Drug Administration.", 'the Division of Antiviral Products, Center for New Drug Evaluation, Food and Drug Administration, Silver Spring, Maryland, USA.', 'to Lisa K. Naeger, PhD, FDA/CDER/OND/DAVP, 10903 New Hampshire Avenue, Building #22, Room 6367, Silver Spring, MD 20993, USA. E-mail: [email\xa0protected]'], 'affiliations': [{'raw_affiliation_string': "These views represent the authors' opinion and not necessarily the views of the Food and Drug Administration.", 'institution_ids': ['https://openalex.org/I4210149736']}, {'raw_affiliation_string': 'to Lisa K. Naeger, PhD, FDA/CDER/OND/DAVP, 10903 New Hampshire Avenue, Building #22, Room 6367, Silver Spring, MD 20993, USA. E-mail: [email\xa0protected]', 'institution_ids': ['https://openalex.org/I1320320070']}, {'raw_affiliation_string': 'the Division of Antiviral Products, Center for New Drug Evaluation, Food and Drug Administration, Silver Spring, Maryland, USA.', 'institution_ids': ['https://openalex.org/I1333606569']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5028775745', 'display_name': 'Kimberly Struble', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210149736', 'display_name': 'Food and Drug Administration', 'ror': 'https://ror.org/05hvrsg85', 'country_code': 'TH', 'type': 'government', 'lineage': ['https://openalex.org/I4210149736']}, {'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}], 'countries': ['TH', 'US'], 'is_corresponding': False, 'raw_author_name': 'Kimberly A Struble', 'raw_affiliation_strings': ["These views represent the authors' opinion and not necessarily the views of the Food and Drug Administration.", 'the Division of Antiviral Products, Center for New Drug Evaluation, Food and Drug Administration, Silver Spring, Maryland, USA.'], 'affiliations': [{'raw_affiliation_string': "These views represent the authors' opinion and not necessarily the views of the Food and Drug Administration.", 'institution_ids': ['https://openalex.org/I4210149736']}, {'raw_affiliation_string': 'the Division of Antiviral Products, Center for New Drug Evaluation, Food and Drug Administration, Silver Spring, Maryland, USA.', 'institution_ids': ['https://openalex.org/I1333606569']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': ['https://openalex.org/A5027568709'], 'corresponding_institution_ids': ['https://openalex.org/I4210149736', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569'], 'apc_list': None, 'apc_paid': None, 'fwci': 3.322, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 49, 'citation_normalized_percentile': {'value': 0.863764, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': '20', 'issue': '6', 'first_page': '847', 'last_page': '853'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10112', 'display_name': 'HIV Research and Treatment', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10082', 'display_name': 'HIV/AIDS Research and Interventions', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/atazanavir', 'display_name': 'Atazanavir', 'score': 0.98413277}, {'id': 'https://openalex.org/keywords/ritonavir', 'display_name': 'Ritonavir', 'score': 0.9791164}, {'id': 'https://openalex.org/keywords/lopinavir', 'display_name': 'Lopinavir', 'score': 0.9774394}, {'id': 'https://openalex.org/keywords/lopinavir/ritonavir', 'display_name': 'Lopinavir/ritonavir', 'score': 0.664451}, {'id': 'https://openalex.org/keywords/protease-inhibitor', 'display_name': 'Protease inhibitor (pharmacology)', 'score': 0.47049546}], 'concepts': [{'id': 'https://openalex.org/C2778414717', 'wikidata': 'https://www.wikidata.org/wiki/Q423467', 'display_name': 'Atazanavir', 'level': 5, 'score': 0.98413277}, {'id': 'https://openalex.org/C2779298103', 'wikidata': 'https://www.wikidata.org/wiki/Q422618', 'display_name': 'Ritonavir', 'level': 5, 'score': 0.9791164}, {'id': 'https://openalex.org/C2777182164', 'wikidata': 'https://www.wikidata.org/wiki/Q422585', 'display_name': 'Lopinavir', 'level': 5, 'score': 0.9774394}, {'id': 'https://openalex.org/C2781392899', 'wikidata': 'https://www.wikidata.org/wiki/Q422618', 'display_name': 'Lopinavir/ritonavir', 'level': 5, 'score': 0.664451}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5722258}, {'id': 'https://openalex.org/C2781143361', 'wikidata': 'https://www.wikidata.org/wiki/Q55761529', 'display_name': 'Protease inhibitor (pharmacology)', 'level': 5, 'score': 0.47049546}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.46646774}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.43895477}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.39817035}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.2733785}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.19181314}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.06872821}], 'mesh': [{'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D016333', 'descriptor_name': 'HIV Protease', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': True}, {'descriptor_ui': 'D017320', 'descriptor_name': 'HIV Protease Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023241', 'descriptor_name': 'Antiretroviral Therapy, Highly Active', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069446', 'descriptor_name': 'Atazanavir Sulfate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': False}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D024882', 'descriptor_name': 'Drug Resistance, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D024882', 'descriptor_name': 'Drug Resistance, Viral', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005838', 'descriptor_name': 'Genotype', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000821', 'qualifier_name': 'virology', 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016333', 'descriptor_name': 'HIV Protease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017320', 'descriptor_name': 'HIV Protease Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009842', 'descriptor_name': 'Oligopeptides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009842', 'descriptor_name': 'Oligopeptides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D010641', 'descriptor_name': 'Phenotype', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011725', 'descriptor_name': 'Pyridines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011725', 'descriptor_name': 'Pyridines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019438', 'descriptor_name': 'Ritonavir', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D019438', 'descriptor_name': 'Ritonavir', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019562', 'descriptor_name': 'Viral Load', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 3, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/01.aids.0000218548.77457.76', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S20605092', 'display_name': 'AIDS', 'issn_l': '0269-9370', 'issn': ['0269-9370', '1473-5571'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://journals.lww.com/aidsonline/Fulltext/2006/04040/Effect_of_baseline_protease_genotype_and_phenotype.8.aspx', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/16549968', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/01.aids.0000218548.77457.76', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S20605092', 'display_name': 'AIDS', 'issn_l': '0269-9370', 'issn': ['0269-9370', '1473-5571'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.84, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 6, 'referenced_works': ['https://openalex.org/W2088008322', 'https://openalex.org/W2096099963', 'https://openalex.org/W2118861418', 'https://openalex.org/W2155312822', 'https://openalex.org/W2164349191', 'https://openalex.org/W2271871949'], 'related_works': ['https://openalex.org/W4289878289', 'https://openalex.org/W2462607742', 'https://openalex.org/W2312621002', 'https://openalex.org/W2171236519', 'https://openalex.org/W2155106983', 'https://openalex.org/W2133425627', 'https://openalex.org/W2131427507', 'https://openalex.org/W2116210217', 'https://openalex.org/W2049969210', 'https://openalex.org/W1968485058'], 'abstract_inverted_index': {'To': [0], 'assess': [1], 'the': [2, 25, 45, 208, 217], 'virologic': [3, 41, 188, 204, 221], 'response': [4, 42, 82, 101, 119, 144, 161, 189, 205, 222], 'rates': [5, 83, 102, 120, 145, 162, 206], 'of': [6, 29, 47, 58, 182, 219], 'atazanavir/ritonavir': [7, 30, 106, 133, 149, 173, 191], 'and': [8, 14, 27, 53, 107, 150, 180, 192, 230, 238], 'lopinavir/ritonavir': [9, 32, 81, 151, 193], 'based': [10, 43, 226], 'on': [11, 19, 44, 216, 227], 'baseline': [12, 48, 54, 114, 127, 183, 199, 228], 'genotype': [13], 'phenotype.Resistance': [15], 'analyses': [16, 213], 'were': [17, 61, 72, 84, 96, 103, 121, 129, 146, 156, 163, 167], 'performed': [18], 'a': [20, 220], 'Bristol-Myers': [21], 'Squibb-sponsored': [22], 'study': [23], 'comparing': [24], 'safety': [26], 'efficacy': [28], 'to': [31, 112, 158, 190, 207, 223, 236], 'in': [33, 74, 154, 194], 'treatment-experienced': [34, 195], 'subjects': [35, 109], 'at': [36, 65, 77, 91, 98], '48': [37], 'weeks.': [38], 'Analyses': [39], 'evaluated': [40], 'presence': [46], 'primary': [49], 'protease': [50, 89, 115, 184], 'inhibitor': [51, 116, 185], 'mutations': [52, 128, 186], 'susceptibility.Less': [55], 'than': [56, 86, 169], '30%': [57, 87], 'atazanavir/ritonavir-treated': [59], 'patients': [60, 239], 'responders': [62], 'if': [63, 123, 152, 165], 'substitutions': [64, 90], 'positions': [66], 'M46,': [67, 92], 'G73,': [68], 'I84': [69, 95], 'or': [70, 94, 125], 'L90': [71], 'present': [73, 97], 'their': [75], 'HIV': [76], 'baseline.': [78, 99], 'In': [79, 197], 'comparison,': [80], 'less': [85], 'when': [88, 240], 'I54,': [93], 'The': [100], 'similar': [104, 147], 'between': [105, 148], 'lopinavir/ritonavir-treated': [108], 'with': [110, 135, 175], 'zero': [111, 157], 'four': [113], 'mutations,': [117], 'but': [118, 160], 'reduced': [122], 'five': [124], 'more': [126], 'present:': [130], '0%': [131], 'for': [132, 137, 172, 177], 'compared': [134, 174], '28%': [136], 'lopinavir/ritonavir.': [138], 'Baseline': [139], 'phenotype': [140], 'results': [141], 'showed': [142], 'that': [143], 'shifts': [153, 166], 'susceptibility': [155, 201], 'five,': [159], 'lower': [164], 'greater': [168], 'five;': [170], '11%': [171], '27%': [176], 'lopinavir/ritonavir.Both': [178], 'type': [179], 'number': [181], 'affected': [187], 'subjects.': [196], 'addition,': [198], 'phenotypic': [200, 231], 'could': [202], 'differentiate': [203], 'two': [209], 'drugs.': [210], 'These': [211], 'resistance': [212], 'provide': [214], 'information': [215], 'likelihood': [218], 'antiretroviral': [224, 242], 'drugs': [225], 'genotypic': [229], 'data,': [232], 'which': [233], 'is': [234], 'valuable': [235], 'physicians': [237], 'choosing': [241], 'regimens.': [243]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2026250203', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 4}], 'updated_date': '2024-12-17T02:20:51.725739', 'created_date': '2016-06-24'}